Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial (Q61959735)
Jump to navigation
Jump to search
scientific article published on 13 October 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial |
scientific article published on 13 October 2009 |
Statements
Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial (English)
A Straumann
S Conus
P Grzonka
H Kita
G Kephart
C Bussmann
C Beglinger
D A Smith
J Patel